KORU Medical Systems Future Growth
How is KORU Medical Systems forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score
1/6Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
6.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 35 | -8 | N/A | N/A | 3 |
12/31/2023 | 31 | -9 | N/A | N/A | 3 |
9/30/2022 | 27 | -8 | -10 | -7 | N/A |
6/30/2022 | 25 | -8 | -8 | -6 | N/A |
3/31/2022 | 24 | -6 | -4 | -3 | N/A |
12/31/2021 | 23 | -5 | -5 | -4 | N/A |
9/30/2021 | 21 | -4 | -6 | -5 | N/A |
6/30/2021 | 21 | -3 | -7 | -6 | N/A |
3/31/2021 | 23 | -3 | -4 | -4 | N/A |
12/31/2020 | 24 | -1 | -2 | -1 | N/A |
9/30/2020 | 26 | 0 | 1 | 2 | N/A |
6/30/2020 | 27 | 0 | 4 | 5 | N/A |
3/31/2020 | 25 | 1 | 1 | 2 | N/A |
12/31/2019 | 23 | 1 | 0 | 0 | N/A |
9/30/2019 | 21 | 0 | -1 | 0 | N/A |
6/30/2019 | 19 | 0 | -1 | -1 | N/A |
3/31/2019 | 18 | 0 | 0 | 0 | N/A |
12/31/2018 | 17 | 1 | 1 | 1 | N/A |
9/30/2018 | 18 | 2 | 2 | 2 | N/A |
6/30/2018 | 17 | 2 | 2 | 2 | N/A |
3/31/2018 | 16 | 1 | 1 | 1 | N/A |
12/31/2017 | 16 | 1 | 1 | 1 | N/A |
2/28/2017 | 12 | -1 | -1 | 0 | N/A |
11/30/2016 | 13 | 0 | 0 | 1 | N/A |
8/31/2016 | 13 | 0 | N/A | 1 | N/A |
5/31/2016 | 13 | 1 | N/A | 2 | N/A |
2/29/2016 | 12 | 1 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KRMD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KRMD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KRMD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KRMD's revenue (11.8% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: KRMD's revenue (11.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KRMD's Return on Equity is forecast to be high in 3 years time